1
00:00:02,400 --> 00:00:06,910
What if a tiny peptide could ask the
pituitary gland to release growth hormone?

2
00:00:07,920 --> 00:00:13,330
Meet ipamorelin: five amino acids designed
to trigger that signal.

3
00:00:14,370 --> 00:00:20,050
In 1998, Kirsten Raun and colleagues at
Novo Nordisk in Denmark reported its

4
00:00:20,050 --> 00:00:20,760
discovery.

5
00:00:21,800 --> 00:00:24,910
Researchers have studied it for almost
three decades.

6
00:00:25,750 --> 00:00:29,870
Ipamorelin activates the ghrelin receptor,
part of the body's growth-hormone

7
00:00:29,870 --> 00:00:30,900
signaling system.

8
00:00:31,680 --> 00:00:37,620
CJC-1295 and tesamorelin act through a
different receptor, the

9
00:00:37,620 --> 00:00:39,920
growth-hormone-releasing hormone receptor.

10
00:00:40,920 --> 00:00:45,640
In the original pig experiments, ipamorelin
stimulated growth hormone without

11
00:00:45,640 --> 00:00:49,590
the same rise in cortisol seen with some
older secretagogues.

12
00:00:50,300 --> 00:00:52,360
That selectivity attracted interest.

13
00:00:53,070 --> 00:00:58,870
A 1999 study in healthy men then showed a
brief growth-hormone response after

14
00:00:58,870 --> 00:01:01,050
intravenous ipamorelin.

15
00:01:01,750 --> 00:01:05,780
It measured hormone release, leaving
long-term health benefits unanswered.

16
00:01:06,440 --> 00:01:09,460
Researchers also explored ghrelin signaling
in the gut.

17
00:01:09,920 --> 00:01:14,470
A randomized trial enrolled 117
bowel-surgery patients.

18
00:01:15,360 --> 00:01:20,220
The ipamorelin group tolerated a meal
sooner numerically, but the difference was

19
00:01:20,220 --> 00:01:21,670
not statistically significant.

20
00:01:22,530 --> 00:01:26,440
So where do the muscle, sleep and
anti-aging claims fit?

21
00:01:27,110 --> 00:01:30,790
A hormone response alone cannot establish
those benefits.

22
00:01:31,510 --> 00:01:36,500
Different receptor pathways also cannot
tell us how much benefit a particular

23
00:01:36,500 --> 00:01:38,360
peptide combination provides.

24
00:01:39,020 --> 00:01:44,080
As of November 2026, ipamorelin has no
FDA-approved medicine.

25
00:01:44,750 --> 00:01:50,190
FDA has raised concerns about immune
reactions, peptide impurities and limited

26
00:01:50,190 --> 00:01:51,330
safety evidence.

27
00:01:52,050 --> 00:01:56,200
Its story connects molecular design, human
hormone measurements and an

28
00:01:56,200 --> 00:02:01,100
unfinished clinical question: which effects
translate into meaningful benefits?

29
00:02:01,640 --> 00:02:03,250
World Peptide Foundation.

30
00:02:03,820 --> 00:02:05,080
Peptides in 2.

31
00:02:05,510 --> 00:02:07,110
Every experience matters.
